%0 Journal Article
%T Effectiveness of Ranolazine to Prevent Myocardial Injury During Elective Percutaneous Coronary Intervention
%A Kasekh Akhtar Jahan
%A SM Mamun Iqbal
%A Sohely Nazneen Eva
%A Syed Ali Ahsan
%J Anwer Khan Modern Medical College Journal
%D 2019
%R https://doi.org/10.3329/akmmcj.v10i1.43664
%X Background: Ranolazine is a novel antianginal drug that reduces intracellular accumulation of calcium ion in ischemic myocardium. A pilot randomized study (n=70) has shown that pretreatment with ranolazine 1000mg twice daily for 7days significantly reduced periprocedural myocardial injury (PMI) in elective Percutaneous coronary intervention (PCI). Our objective was to detect whether similar effect could be obtained by ranolazine pretreatment through an interventional study
%U https://www.banglajol.info/index.php/AKMMCJ/article/view/43664